Open access
Open access
Powered by Google Translator Translator

Hematology (all articles)

Updated Guidelines to Reduce Venous Thromboembolism in Trauma Patients

29 Jun, 2020 | 09:03h | UTC

Updated Guidelines to Reduce Venous Thromboembolism in Trauma Patients: A Western Trauma Association Critical Decisions Algorithm – Trauma and Acute Care Surgery

 


Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges

23 Jun, 2020 | 08:19h | UTC

Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges – Journal of the American Heart Association

 


Blood Type Linked to Outcomes in Covid-19 Patients: Type O May Be Protective and Type A May Increase Risk

18 Jun, 2020 | 09:12h | UTC

Genomewide Association Study of Severe Covid-19 with Respiratory Failure – New England Journal of Medicine

Commentary: Study ties blood type to COVID-19 risk; O may help, A hurt – Associated Press

 


Position Paper: Guidance on Diagnosis, Prevention and Treatment of Thromboembolic Complications in COVID-19

18 Jun, 2020 | 09:03h | UTC

Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy – Hematology, Transfusion and Cell Therapy

 


Thromboelastographic Results and Hypercoagulability Syndrome in Patients with Coronavirus Disease 2019 Who Are Critically Ill

16 Jun, 2020 | 07:58h | UTC

Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill – JAMA Network Open

Commentary: Researchers recommend TEG test to identify undetected blood clots in COVID-19 ICU patients – Baylor College of Medicine

 


[Preprints Studies] Relationship Between Blood Group and Risk of Infection and Death in COVID-19

11 Jun, 2020 | 09:28h | UTC

Study 1: Relationship Between Blood Group and Risk of Infection and Death in COVID-19: a live Meta-Analysis – medRxiv AND Commentary:  Blood type plays role in SARS-CoV-2 infection – News Medical

Study 2: The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis – medRxiv AND Commentary:  The Role Of Blood Type In Covid-19 Infection And Respiratory Failure – Forbes

 


Risk of Hospitalization with Hemorrhage Among Older Adults Taking Clarithromycin vs. Azithromycin and Direct Oral Anticoagulants

9 Jun, 2020 | 04:33h | UTC

Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants – JAMA Internal Medicine

 


CHEST Guideline: Prevention, Diagnosis and Treatment of Venous Thromboembolism in Patients with COVID-19

8 Jun, 2020 | 04:39h | UTC

Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report – CHEST

 


Convalescent Plasma Therapy Shows Promise for Severe COVID-19 in Small Randomized Trial

4 Jun, 2020 | 05:08h | UTC

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial – JAMA

Editorial: A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals – JAMA

 


Blood Vessel Attack Could Trigger Coronavirus’ Fatal ‘Second Phase’

3 Jun, 2020 | 03:56h | UTC

Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ – Science

 


Observational Study: Many Patients with Covid-19 in the ICU Develop Thromboembolism Despite Routine Prophylaxis

29 May, 2020 | 03:17h | UTC

Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019 – Critical Care Medicine

 


Meta-Analysis: Direct Oral Anticoagulants vs. Low‐molecular‐weight Heparin for the Treatment of Cancer‐associated Thrombosis

29 May, 2020 | 03:03h | UTC

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials – Research and Practice in Thrombosis and Haemostasis

“In patients with cancer‐associated VTE, DOACs are more effective in preventing recurrent VTE compared to LMWH. However, risk of bleeding is increased with DOACs, especially in patients with GI cancer.”

 


Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19

27 May, 2020 | 02:21h | UTC

Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis – Canadian Medical Association Journal

 


Clinical Guidance: Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic

25 May, 2020 | 01:43h | UTC

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum – Journal of Thrombosis and Thrombolysis

Related: Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet AND COVID-19 and its implications for thrombosis and anticoagulation – Blood AND Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines – Thrombosis and Haemostasis AND Thrombosis and COVID-19: FAQs For Current Practice – American College of Cardiology

 


Hemostasis Disorders in Critically Ill Patients with COVID-19

18 May, 2020 | 02:08h | UTC

Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19 – Intensive Care Medicine

 

Related Commentary on Twitter

 


[Preprint] Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients

15 May, 2020 | 03:50h | UTC

Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients – medRxiv

Commentary: Convalescent plasma is safe to treat COVID-19: nationwide study – NBC News

 


Systematic Review: Plasma from People who Have Recovered from COVID-19 to Treat Individuals with COVID-19

15 May, 2020 | 03:48h | UTC

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a rapid review – Cochrane Library

Summary: Plasma from people who have recovered from COVID-19 to treat individuals with COVID-19 – Cochrane Library

 


Coagulation Abnormalities and Thrombosis in Patients with COVID-19

12 May, 2020 | 03:16h | UTC

Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet

 

Related Commentary on Twitter

 


NCCN Guideline: Hematopoietic Cell Transplantation

10 May, 2020 | 23:53h | UTC

Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

 


Autopsies Find High Incidence of Venous Thromboembolism in Patients with Covid-19

7 May, 2020 | 09:18h | UTC

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study – Annal of Internal Medicine

Related Study: Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 – Journal of Thrombosis and Haemostasis

 


Observational Study: Anticoagulation Linked to Increased Survival Among Hospitalized Patients with COVID-19

7 May, 2020 | 09:16h | UTC

Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 – Journal of the American College of Cardiology

Commentaries: Giving blood thinners to severely ill Covid-19 patients is gaining ground – STAT AND Blood thinners may improve survival among hospitalized COVID-19 patients – Mount Sinai Hospital AND Anticoagulation Associated With Improved Outcomes in Hospitalized COVID-19 Patients – American College of Cardiology AND Expert reaction to study looking at blood thinners in hospitalised patients with COVID-19 – Science Media Centre

 


Case Reports: Acute Limb Ischemia in Two Young Patients with COVID-19

7 May, 2020 | 09:15h | UTC

Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19 – The Lancet

 


Despite Anticoagulation, Patients with Severe SARS-CoV-2 Infection are at Increased Risk of Developing Thrombosis

6 May, 2020 | 03:40h | UTC

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study – Intensive Care Medicine

 


Meta-Analysis: Effects of Restrictive vs. Liberal Transfusion Strategies on Longer-term Outcomes After Cardiac Surgery

5 May, 2020 | 03:54h | UTC

The effect of restrictive versus liberal transfusion strategies on longer-term outcomes after cardiac surgery: a systematic review and meta-analysis with trial sequential analysis – Canadian Journal of Anesthesia

Related: Randomized Trial: In Patients Undergoing Cardiac Surgery, A Restrictive Transfusion Approach Does Not Increase the Risk of Acute Kidney Injury (selection of studies on the subject)

 


Short Review: Coagulopathy Associated with COVID-19

3 May, 2020 | 22:09h | UTC

Coagulopathy associated with COVID-19 – Canadian Medical Association Journal

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.